首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
【24h】

Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.

机译:10例恶性嗜铬细胞瘤的临床和病理数据:在单个机构中进行长期随访。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Malignant pheochromocytomas are rare. Many controversies still exists in clinical practice. We report the clinical and histological data of long-term follow up in 10 patients with malignant pheochromocytoma. METHODS: The clinical charts of 10 patients with malignant pheochromocytoma from a single institute were reviewed. The diagnosis of pheochromocytoma was confirmed at surgery. All patients had metastases in sites where chromaffin tissue was normally absent. RESULTS: The median follow-up period was 5.5 years (range, 2-20 years). Extra-adrenal tumors occurred in four patients including paraganglioma tumors in three cases and bladder tumor in one case. Regional lymph node metastases were noted in six patients. Distant metastases were located in the lungs of two patients, in the bones of two patients and in the liver of one patient. Histological characteristics were not helpful for diagnosis of malignancy and for prediction of prognosis. Metastases were present in postoperative pathology in seven patients. In another three patients, metastases were discovered 6 months to 10 years after surgery. Three patients received chemotherapy and one patient received combination therapy of high-dose (131)I-meta-iodobenzylguanidine ((131)I-MIBG) therapy and chemotherapy. All patients achieved long-term survival except for two who died of metastasis 1.5 years and 2 years after diagnosis. CONCLUSIONS: Early complete resection and adjunctive lymphadenectomy can cure malignancy. Close long-term follow up for more than 10 years after surgery is necessary in patients with pheochromocytoma. The possibility of malignancy should be kept in mind even though the initial pathology is benign.
机译:背景:恶性嗜铬细胞瘤很少见。在临床实践中仍然存在许多争议。我们报告10例恶性嗜铬细胞瘤患者的长期随访的临床和组织学数据。方法:回顾了单间研究所的10例恶性嗜铬细胞瘤患者的临床图表。手术中证实了嗜铬细胞瘤的诊断。所有患者均在通常不存在嗜铬组织的部位发生转移。结果:中位随访期为5。5年(范围为2-20年)。肾上腺外肿瘤4例,其中副神经节瘤3例,膀胱肿瘤1例。在六名患者中发现了局部淋巴结转移。远处转移位于两名患者的肺部,两名患者的骨骼和一名患者的肝脏中。组织学特征无助于恶性肿瘤的诊断和预后的预测。 7例患者的术后病理中有转移。在另外三例患者中,在术后6个月至10年发现转移。三名患者接受了化疗,一位患者接受了大剂量(131)I-间碘碘苄胍((131)I-MIBG)治疗和化疗的联合治疗。除两名在诊断后1.5年和2年因转移死亡的患者外,所有患者均获得了长期生存。结论:早期完全切除和辅助淋巴结清扫术可以治愈恶性肿瘤。对于嗜铬细胞瘤患者,必须在手术后进行密切的长期随访,超过10年。即使最初的病理是良性的,也应记住恶性肿瘤的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号